— Know what they know.
Not Investment Advice

EVAX NASDAQ

Evaxion Biotech A/S
1W: -4.2% 1M: +4.2% 3M: -5.3% YTD: -32.1% 1Y: -27.9% 3Y: -92.4% 5Y: -99.3%
$3.20
+0.02 (+0.63%)
 
Weekly Expected Move ±5.9%
$3 $3 $3 $3 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 55 · $20.2M mcap · 5M float · 2.88% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
37.5 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -260.4%  ·  5Y Avg: -113.4%
Cost Advantage ★
54
Intangibles
45
Switching Cost
40
Network Effect
14
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. EVAX has No discernible competitive edge (37.5/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -260.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$10
Avg Target
$10
High
Based on 3 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$10.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-09 Lake Street — $11 $9 -2 +192.2% $3.08
2026-02-19 Maxim Group — Initiated $10 — +207.7% $3.25
2025-10-20 Lake Street Thomas Flaten Initiated $11 — +54.1% $7.14
2025-09-25 H.C. Wainwright — Initiated $16 — +253.2% $4.53

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. EVAX receives an overall rating of C. Strongest factors: P/B (5/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-08-24 C- C
2026-07-09 D+ C-
2026-05-14 C- D+
2026-03-02 C C-
2026-02-23 C- C
2026-02-06 C C-
2026-01-03 D+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
45
Earnings Quality
54
Growth
88
Value
42
Momentum
80
Safety
0
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-10.09
Distress Zone
Piotroski F-Score
6/9
✗ ✗ ✓ ✓ ✓ ✓ ✓ ✗ ✓
Beneish M-Score
—
—
Ohlson O-Score
-3.22
Bankruptcy prob: 3.8%
Low Risk
Credit Rating
B
Score: 29.7/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.95x
Accruals: -2.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EVAX scores -10.09, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EVAX scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EVAX's implied 3.8% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EVAX receives an estimated rating of B (score: 29.7/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.52x
PEG
0.00x
P/S
2.70x
P/B
0.14x
P/FCF
-0.16x
P/OCF
—
EV/EBITDA
0.56x
EV/Revenue
-0.75x
EV/EBIT
0.56x
EV/FCF
0.68x
Earnings Yield
-669.33%
FCF Yield
-636.42%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. EVAX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.902
NI / EBT
×
Interest Burden
0.966
EBT / EBIT
×
EBIT Margin
-1.325
EBIT / Rev
×
Asset Turnover
0.358
Rev / Assets
×
Equity Multiplier
2.655
Assets / Equity
=
ROE
-109.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EVAX's ROE of -109.8% is driven by Asset Turnover (0.358), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.90 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1421 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.20
Median 1Y
$0.60
5th Pctile
$0.07
95th Pctile
$5.10
Ann. Volatility
124.6%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
45
-2.2% YoY
Revenue / Employee
$167,801
Rev: $7,551,040
Profit / Employee
$-171,791
NI: $-7,730,588
SGA / Employee
$144,574
Avg labor cost proxy
R&D / Employee
$215,346
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -97.1% -75.6% -96.8% -1.2% -1.6% -1.1% -1.4% -2.2% -4.5% -12.4% -3.2% -8.0% 8.6% 3.3% -2.1% -3.2% -65.0% -1.0% -83.0% -1.1% -1.10%
ROA -67.0% -61.1% -69.0% -78.4% -95.7% -74.5% -76.7% -96.7% -1.2% -1.3% -68.1% -95.1% -84.5% -83.3% -55.7% -63.6% -24.1% -37.7% -39.9% -41.4% -41.37%
ROIC -1.7% -5.2% -4.1% -4.5% 4.9% -3.7% 5.5% -3.3% -3.9% -31.6% 1.7% -4.0% 2.6% -3.4% 1.5% -4.0% -1.2% -5.6% 1.4% -2.6% -2.60%
ROCE -83.3% -68.5% -72.1% -80.9% -86.4% -1.3% -1.1% -1.9% -3.4% -3.8% -65.1% -1.3% -73.7% -1.5% -58.6% -78.3% -20.4% -36.2% -46.0% -61.1% -61.10%
Gross Margin — — — — — — — — — 1.0% 1.0% 1.0% 1.0% 1.0% — 1.0% 1.0% — — — —
Operating Margin — — — — — — — — — -59.8% -86.2% -29.7% -57.4% -33.0% — -117.3% 40.3% — — — —
Net Margin — — — — — — — — — -62.0% 23.4% -40.2% -64.1% -29.7% — -130.6% 61.6% — — — —
EBITDA Margin — — — — — — — — — -62.9% 24.0% -40.1% -54.6% -45.2% — -129.3% 76.2% — — — —
FCF Margin — — — — — — — — — -267.0% -140.5% -55.2% -4.7% -5.0% -4.7% -4.5% -1.7% -1.5% -1.3% -1.1% -1.10%
OCF Margin — — — — — — — — — -264.2% -139.2% -54.8% -4.6% -4.9% -4.7% -4.4% -1.7% -1.5% -1.3% -1.1% -1.10%
ROE 3Y Avg snapshot only -4.99%
ROE 5Y Avg snapshot only -5.17%
ROA 3Y Avg snapshot only -65.94%
ROIC Economic snapshot only -41.64%
Cash ROA snapshot only -42.41%
Cash ROIC snapshot only -3.12%
CROIC snapshot only -3.12%
NOPAT Margin snapshot only -91.63%
Pretax Margin snapshot only -1.28%
R&D / Revenue snapshot only 1.37%
SGA / Revenue snapshot only 74.73%
SBC / Revenue snapshot only 1.19%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -14.31 -4.88 -3.34 -2.37 -2.79 -2.31 -1.54 -1.81 -1.18 -1.06 -1.27 -1.29 -1.87 -0.43 -0.15 -0.23 -0.77 -3.96 -3.18 -0.15 -0.522
P/S Ratio — — — — — — — — — 320.91 150.45 70.56 6.52 1.36 0.62 0.85 0.54 4.06 4.12 0.17 2.698
P/B Ratio 13.89 3.69 3.32 2.84 5.08 6.45 5.54 17.48 -10.53 -4.95 7.16 15.65 290.28 -2.75 0.20 0.43 0.25 1.79 2.35 0.14 0.140
P/FCF -12.17 -5.14 -3.22 -2.33 -2.80 -2.05 -1.50 -1.74 -1.24 -1.20 -1.07 -1.28 -1.40 -0.27 -0.13 -0.19 -0.32 -2.69 -3.17 -0.16 -0.157
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -13.27 -3.72 -2.54 -1.74 -2.15 -2.19 -1.12 -1.96 -1.48 -1.30 -0.47 -1.45 -1.51 -0.79 1.07 0.06 1.08 -1.70 -1.16 0.56 0.564
EV/Revenue — — — — — — — — — 393.34 55.84 79.54 5.13 2.87 -4.80 -0.24 -0.84 1.97 1.67 -0.75 -0.748
EV/EBIT -13.27 -3.72 -2.54 -1.74 -2.15 -2.19 -1.12 -1.96 -1.48 -1.30 -0.47 -1.45 -1.51 -0.79 1.07 0.06 1.06 -1.70 -1.16 0.56 0.564
EV/FCF -11.75 -3.92 -2.44 -1.70 -2.07 -1.94 -1.08 -1.87 -1.57 -1.47 -0.40 -1.44 -1.10 -0.58 1.03 0.05 0.50 -1.31 -1.28 0.68 0.681
Earnings Yield -7.0% -20.5% -29.9% -42.3% -35.8% -43.3% -64.9% -55.4% -85.0% -94.4% -78.7% -77.5% -53.4% -2.3% -6.5% -4.4% -1.3% -25.2% -31.5% -6.7% -6.69%
FCF Yield -8.2% -19.5% -31.1% -42.9% -35.7% -48.7% -66.5% -57.5% -80.8% -83.2% -93.4% -78.3% -71.4% -3.7% -7.5% -5.2% -3.1% -37.2% -31.6% -6.4% -6.36%
PEG Ratio snapshot only 0.001
Price/Tangible Book snapshot only 0.136
EV/Gross Profit snapshot only -0.748
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.16 8.03 7.55 6.47 — 4.51 — 2.81 1.46 1.18 — 2.80 — 2.01 — 3.42 — 5.85 — 5.06 5.062
Quick Ratio 4.16 8.03 7.55 6.47 — 4.51 — 2.81 1.46 1.18 — 2.80 — 2.01 — 3.42 — 5.85 — 5.06 5.062
Debt/Equity 0.23 0.11 0.39 0.48 0.00 1.24 0.00 4.14 -3.77 -2.30 0.00 8.37 0.00 -6.11 0.00 1.81 0.00 0.44 0.00 0.75 0.745
Net Debt/Equity -0.49 -0.88 -0.80 -0.77 -1.32 -0.35 -1.56 1.33 — — -4.50 1.99 -61.84 — -1.73 -0.56 -0.64 -0.92 -1.40 -0.72 -0.723
Debt/Assets 0.16 0.09 0.25 0.29 0.00 0.47 0.00 0.63 0.86 0.84 0.00 0.69 0.00 0.81 0.00 0.50 0.00 0.26 0.00 0.37 0.367
Debt/EBITDA -0.23 -0.15 -0.39 -0.41 -0.00 -0.44 -0.00 -0.43 -0.42 -0.49 -0.00 -0.69 -0.00 -0.83 -0.00 -0.85 -0.00 -0.86 -0.00 -0.72 -0.716
Net Debt/EBITDA 0.48 1.16 0.81 0.65 0.75 0.13 0.44 -0.14 -0.31 -0.24 0.80 -0.16 0.41 -0.42 1.21 0.26 1.77 1.80 1.70 0.69 0.695
Interest Coverage -19.95 -26.84 -33.81 -47.36 -23.96 -15.30 -13.91 -14.52 -18.62 -24.61 -18.05 -18.55 -10.92 -14.25 -14.70 -13.11 -3.03 -9.97 -13.40 -13.58 -13.584
Equity Multiplier 1.45 1.24 1.56 1.69 2.03 2.65 3.12 6.61 -4.37 -2.73 8.70 12.16 205.20 -7.56 2.45 3.61 1.79 1.67 1.79 2.03 2.033
Cash Ratio snapshot only 4.469
Debt Service Coverage snapshot only -13.584
Cash to Debt snapshot only 1.970
FCF to Debt snapshot only -1.158
Defensive Interval snapshot only 357.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.24 0.26 0.14 0.17 0.34 0.37 0.31 0.36 0.358
Inventory Turnover — — 0.00 — — — — — — — — — — — — — — — — — —
Receivables Turnover — — 0.00 — — — — — — — — — — 3.60 — 7.35 — 5.18 — 5.50 5.505
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00 — 0.00 — 0.00 — 0.00 —
DSO — — — — — — — — — 0 0 0 0 101 0 50 0 71 0 66 66.3 days
DIO — — — — — — — — — — — — — — — — — — — — —
DPO — — — — — — — — — — — — — — — — — — — — —
Cash Conversion Cycle — — — — — — — — — — — — — — — — — — — — —
Fixed Asset Turnover snapshot only 2.566
Cash Velocity snapshot only 0.535
Capital Intensity snapshot only 2.587
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — — — — — — — 44.8% 25.6% 10.4% 1.3% 1.3% 1.3% 1.4% 1.36%
Net Income — — -5.4% -1.2% -52.6% 5.5% 9.9% -1.5% 0.8% 4.5% 37.8% 38.0% 53.2% 52.2% 9.2% 21.2% 52.7% 27.0% 26.8% 27.7% 27.74%
EPS — — -3.9% -76.1% -23.0% 15.2% 19.1% 10.6% 14.5% 15.7% 65.6% 69.0% 76.6% 69.6% 4.2% 3.6% 40.9% 87.8% 90.3% -91.5% -91.51%
FCF — — -5.2% -98.4% -29.4% -11.9% 11.2% -3.7% 5.4% 25.2% 28.1% 39.7% 34.0% 15.0% 11.8% 7.8% 15.6% 31.4% 36.2% 41.9% 41.85%
EBITDA — — -5.2% -1.1% -41.0% 5.7% 10.9% -1.6% -4.0% 4.6% 36.9% 37.4% 54.6% 45.1% 0.2% 12.5% 46.7% 27.9% 26.1% 25.5% 25.49%
Op. Income — — -4.2% -1.2% -46.1% 2.2% 6.2% 5.6% 7.5% 11.6% 20.5% 23.0% 38.5% 34.0% 29.7% 26.9% 38.9% 37.3% 35.3% 37.8% 37.77%
OCF Growth snapshot only 41.82%
Asset Growth snapshot only -13.67%
Equity Growth snapshot only 53.08%
Debt Growth snapshot only -37.03%
Shares Change snapshot only -62.27%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — -13.4% -18.0% -14.3% -32.3% -15.0% -12.9% 2.7% 8.9% 4.9% 5.0% 4.97%
Assets 5Y — — — — — — — — — — — — — — — — — — -7.5% -6.9% -6.87%
Equity 3Y — — — — — — — — — — -54.6% -61.4% -83.6% — -26.9% -32.4% 7.0% 27.1% 26.2% 55.5% 55.50%
Book Value 3Y — — — — — — — — — — -67.1% -72.8% -88.4% — -41.0% -45.0% -12.9% -42.2% -46.3% 82.7% 82.71%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — 1.00 1.00 1.00 0.75 0.60 0.60 0.60 0.62 0.63 0.67 0.87 0.88 0.65 0.66 0.661
Earnings Stability — — — — — — 0.65 0.77 0.73 0.99 0.14 0.06 0.08 0.74 0.02 0.03 0.43 0.87 0.02 0.20 0.198
Margin Stability — — — — — — — — — — — — — — — — — 1.00 1.00 1.00 1.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.50 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — 0.96 0.99 1.00 0.98 0.85 0.85 0.50 0.50 0.96 0.92 0.50 0.89 0.89 0.89 0.889
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — -3.02 -8.83 — — -3.35 -6.70 — — 3.32 8.98 — — 2.73 6.12 6.121
Gross Margin Trend — — — — — — — — — — — — — — — — — 0.00 0.00 0.00 0.000
FCF Margin Trend — — — — — — — — — — — — — — — — — 134.49 71.28 28.74 28.737
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.10 0.89 0.99 0.98 0.98 1.11 1.02 1.03 0.94 0.87 1.18 1.00 1.33 1.56 1.15 1.18 2.39 1.47 1.00 0.95 0.950
FCF/OCF 1.07 1.06 1.05 1.03 1.02 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 0.951
CapEx/Revenue — — — — — — — — — 2.9% 1.3% 38.7% 1.9% 2.0% 1.3% 0.7% 0.0% 0.0% 0.1% 0.1% 0.11%
Accruals Ratio 0.07 -0.06 -0.00 -0.01 -0.02 0.08 0.01 0.03 -0.07 -0.16 0.12 0.00 0.28 0.47 0.08 0.11 0.33 0.18 0.00 -0.02 -0.021
Sloan Accruals snapshot only -0.006
Cash Flow Adequacy snapshot only -993.167
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -12.1% -45.0% -29.6% -45.4% -37.8% -0.1% -0.4% -0.5% -0.7% -0.9% -12.9% -23.4% -32.0% -2.4% -6.3% -5.4% -4.0% -59.6% -64.1% -16.7% -16.68%
Total Shareholder Return -12.1% -45.0% -29.6% -45.4% -37.8% -0.1% -0.4% -0.5% -0.7% -0.9% -12.9% -23.4% -32.0% -2.4% -6.3% -5.4% -4.0% -59.6% -64.1% -16.7% -16.68%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.92 0.99 1.00 1.02 1.03 0.97 0.97 0.97 0.97 0.97 0.95 0.95 0.94 0.93 0.95 0.94 0.85 0.89 0.91 0.90 0.902
Interest Burden (EBT/EBIT) 1.05 1.01 1.00 0.99 1.01 1.03 1.04 1.04 1.02 1.04 1.05 1.05 1.09 0.93 0.95 0.95 1.05 0.99 0.98 0.97 0.966
EBIT Margin — — — — — — — — — -302.40 -118.90 -54.78 -3.39 -3.65 -4.49 -4.22 -0.79 -1.16 -1.44 -1.32 -1.325
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.24 0.26 0.14 0.17 0.34 0.37 0.31 0.36 0.358
Equity Multiplier 1.45 1.24 1.40 1.47 1.71 1.53 1.87 2.24 3.64 9.77 4.70 8.44 -10.20 -3.98 3.71 5.04 2.69 2.66 2.08 2.65 2.655
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-33.67 $-45.28 $-45.29 $-40.57 $-41.40 $-38.40 $-36.64 $-36.27 $-35.39 $-32.38 $-12.60 $-11.24 $-8.30 $-9.85 $-12.07 $-10.83 $-4.91 $-1.20 $-1.17 $-20.75 $-20.75
Book Value/Share $34.69 $59.87 $45.57 $33.81 $22.74 $13.76 $10.20 $3.75 $-3.95 $-6.92 $2.23 $0.93 $0.05 $-1.54 $9.34 $5.63 $15.02 $2.66 $1.58 $22.86 $22.86
Tangible Book/Share $34.49 $59.70 $45.41 $33.67 $22.74 $13.76 $10.20 $3.75 $-3.95 $-6.92 $2.23 $0.93 $0.05 $-1.54 $9.34 $5.63 $15.02 $2.66 $1.58 $22.86 $22.86
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.11 $0.11 $0.21 $2.39 $3.12 $2.98 $2.87 $6.92 $1.17 $0.90 $17.97 $17.97
FCF/Share $-39.59 $-42.99 $-47.11 $-41.20 $-41.26 $-43.19 $-37.57 $-37.63 $-33.63 $-28.53 $-14.94 $-11.35 $-11.10 $-15.44 $-13.90 $-12.80 $-11.71 $-1.77 $-1.17 $-19.73 $0.00
OCF/Share $-37.12 $-40.48 $-45.04 $-39.91 $-40.38 $-42.71 $-37.28 $-37.37 $-33.42 $-28.22 $-14.81 $-11.27 $-11.06 $-15.38 $-13.86 $-12.78 $-11.71 $-1.77 $-1.17 $-19.71 $0.00
Cash/Share $24.89 $59.37 $54.24 $42.37 $29.96 $21.85 $15.89 $10.52 $3.77 $8.17 $10.06 $5.91 $3.31 $4.71 $16.14 $13.34 $9.57 $3.63 $2.21 $33.57 $33.57
EBITDA/Share $-35.04 $-45.32 $-45.29 $-40.19 $-39.79 $-38.35 $-36.26 $-35.98 $-35.65 $-32.30 $-12.65 $-11.26 $-8.10 $-11.29 $-13.31 $-12.05 $-5.40 $-1.36 $-1.30 $-23.80 $-23.80
Debt/Share $8.05 $6.81 $17.77 $16.30 $0.00 $16.99 $0.00 $15.51 $14.90 $15.91 $0.00 $7.75 $0.00 $9.41 $0.00 $10.21 $0.00 $1.17 $0.00 $17.04 $17.04
Net Debt/Share $-16.83 $-52.56 $-36.46 $-26.07 $-29.96 $-4.85 $-15.89 $4.99 $11.14 $7.74 $-10.06 $1.85 $-3.31 $4.71 $-16.14 $-3.13 $-9.57 $-2.45 $-2.21 $-16.53 $-16.53
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -10.088
Altman Z-Prime snapshot only -21.471
Piotroski F-Score 1 2 2 2 2 0 1 0 1 2 2 2 3 4 3 5 3 4 2 6 6
Beneish M-Score — — — — — — — — — — — — — 0.45 — -3.35 0.28 — — — —
Ohlson O-Score snapshot only -3.222
ROIC (Greenblatt) snapshot only -63.45%
Net-Net WC snapshot only $14.41
EVA snapshot only $-7128324.51
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B
Credit Score 58.17 61.07 35.76 30.80 28.56 27.96 28.34 23.16 20.00 19.92 29.15 22.24 28.73 20.00 28.45 26.64 28.63 31.14 28.63 29.72 29.718
Credit Grade snapshot only 15
Credit Trend snapshot only 3.075
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 20
Sector Credit Rank snapshot only 21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms